Haixia Sun

Title: Haixia Sun: Innovator in Embolism Material for Blood Vessels

Introduction

Haixia Sun is a prominent inventor based in Hubei, China. She has made significant contributions to the field of medical materials, particularly in the development of embolism materials for blood vessels. Her innovative work has the potential to enhance therapeutic options for patients with tumors in hypervascular and parenchymal visceral organs.

Latest Patents

Haixia Sun holds a patent for an "Embolism material for blood vessel, preparation method therefor and use thereof in preparation of drugs." This patent describes the use of poly(N-isopropylacrylamide-co-butyl methacrylate) in creating an embolism material. The embolism material comprises a dispersion medium that includes an electrolyte, a contrast agent, a pH regulator, and water. The specific concentrations of the polymer, electrolyte, and contrast agent are crucial for its effectiveness, making it suitable for embolization therapy.

Career Highlights

Haixia Sun is currently associated with Anew-Med Life Science (Wuhan) Co., Ltd. Her work at this company focuses on advancing medical technologies and improving patient outcomes through innovative materials. With her expertise, she has contributed to the development of solutions that address critical medical challenges.

Collaborations

Haixia Sun has collaborated with notable colleagues, including Hong Liu and Han Li. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of medical research.

Conclusion

Haixia Sun's contributions to the development of embolism materials for blood vessels highlight her role as a leading inventor in the medical field. Her innovative approaches and collaborations continue to pave the way for advancements in therapeutic options for patients.